0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.44%
Revenue growth under 50% of 0360.HK's 18.24%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.98%
Positive gross profit growth while 0360.HK is negative. John Neff would see a clear operational edge over the competitor.
-0.35%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.35%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2991.74%
Positive net income growth while 0360.HK is negative. John Neff might see a big relative performance advantage.
2880.00%
Positive EPS growth while 0360.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2860.00%
Positive diluted EPS growth while 0360.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.27%
Slight or no buybacks while 0360.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Dividend reduction while 0360.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
100.00%
Positive OCF growth while 0360.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
100.00%
FCF growth similar to 0360.HK's 100.00%. Walter Schloss would attribute it to parallel capital spending and operational models.
-66.05%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-69.39%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-49.38%
Negative 3Y CAGR while 0360.HK stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
100.00%
Positive OCF/share growth while 0360.HK is negative. John Neff might see a comparative advantage in operational cash viability.
100.00%
3Y OCF/share CAGR of 100.00% while 0360.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
36.90%
Net income/share CAGR 1.25-1.5x 0360.HK's 31.09%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
125.08%
5Y net income/share CAGR above 1.5x 0360.HK's 83.27%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1534.11%
3Y net income/share CAGR of 1534.11% while 0360.HK is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
19.37%
Positive growth while 0360.HK is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-6.83%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-3.85%
Negative 3Y equity/share growth while 0360.HK is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0360.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0360.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
14.65%
Our AR growth while 0360.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-19.50%
Inventory is declining while 0360.HK stands at 19.62%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.10%
Asset growth above 1.5x 0360.HK's 0.48%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.88%
Positive BV/share change while 0360.HK is negative. John Neff sees a clear edge over a competitor losing equity.
83.53%
We have some new debt while 0360.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
18.55%
R&D growth of 18.55% while 0360.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-5.63%
We cut SG&A while 0360.HK invests at 99.77%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.